Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,782,990,023
New position
Shares Held
34,393,013
first reported quarter
Ownership
2.22%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.6836217867856.ToString("F0")%
Shared 0.ToString("F0")%
None 0.31637821321441073.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International Investors holds $19,740,296,250 across 8 Drug Manufacturers - General names. AZN ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
34,393,013 | $6,782,990,023 | |
| 2 | LLY |
ELI LILLY & Co
|
6,116,692 | $5,625,949,800 | |
| 3 | ABBV |
AbbVie Inc.
|
14,418,993 | $3,135,986,787 | |
| 4 | AMGN |
Amgen Inc
|
7,122,275 | $2,505,972,458 | |
| 5 | JNJ |
Johnson & Johnson
|
2,617,363 | $639,788,211 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,432,445 | $511,427,789 | |
| 7 | NVO |
Novo Nordisk A S
|
11,795,850 | $433,497,487 | |
| 8 | MRK |
Merck & Co., Inc.
|
870,261 | $104,683,695 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,782,990,023 | 34,393,013 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||